6505--Budesonide/Formoterol INH
Closed Pre-Solicitation Posted
This opportunity was awarded. See the award notice from , or the latest solicitation from .
- Solicitation number
- 36E79726R0013
- Agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Veterans Affairs National Acquisition Center is seeking to procure Budesonide/Formoterol inhalers through an unrestricted procurement for use across multiple federal agencies, including the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Centers. The formal Request for Proposal (RFP) 36E79726R0013 will be issued electronically in commercial item format in accordance with FAR Part 12 on or about March 30, 2026, with a tentative closing date of April 13, 2026 at 2:30 PM Central Time. Offerors must demonstrate their ability to provide an uninterrupted source of supply and must provide the exact drug name as it appears on the label along with a unique NDC number specific to their offering. While specific evaluation criteria are not detailed in the pre-solicitation notice, the government will award the contract to the responsible offeror best able to meet the requirement. All solicitation documents and amendments will be available exclusively through SAM.gov, and interested parties should direct technical questions to Kenneth Lay at Kenneth.Lay@va.gov or (708) 786-4879.
This is an unrestricted procurement with no set-aside designations, meaning all responsible sources are eligible to submit proposals. The contract period will consist of one year with four pre-priced one-year option periods, providing potential five-year coverage. The estimated annual requirements total 942,316 canisters, comprising 722,021 units of Budesonide 160mcg/Formoterol Fumarate 4.5mcg/spray inhalers and 220,295 units of Budesonide 80mcg/Formoterol Fumarate 4.5mcg/spray inhalers, each in 10.2-gram packages. No incumbent contractor or award value is identified in the pre-solicitation notice. The NAICS classification for this procurement is 325412 (Pharmaceutical Preparation Manufacturing), and offerors are advised to continuously monitor SAM.gov for any solicitation amendments or changes prior to proposal submission.
Notice text
PRE-SOLICITATION NOTICE:Â The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79726R0013 for an unrestricted procurement for Budesonide/Formoterol INH, for the Department of Veterans Affairs (VA) (inclusive of Consolidated Mail Order Pharmacies (CMOPs) and Option 2 State Veterans Homes (SVH)), Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC).Â
VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s and DOD s respective Pharmaceutical Prime Vendor Programs.Â
Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have an NDC number that is unique to the offeror. Solicitation # 36E79726R0013 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about March 30, 2026, with a tentative closing date of April 13, 2026. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at sam.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check Contracting Opportunities at SAM.gov for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Kenneth Lay. Questions can be e-mailed to Kenneth.Lay@va.gov. Â
The estimated annual requirements are as follows:Â
REQUIREMENT DESCRIPTIONÂ
ITEMÂ
DESCRIPTIONÂ
PACKAGE SIZE (CANISTERS)
TOTAL ESTIMATED ANNUAL USAGE (CANISTERS)
1
BUDESONIDE 160MCG/FORMOTEROL FUM 4.5MCG/SPRAY INHL,ORAL,10.2GM
1
722,021
2
BUDESONIDE 80MCG/FORMOTEROL FUM 4.5MCG/SPRAY INHL,ORAL,10.2GM
1
220,295
Files
| File | Type | Posted |
|---|---|---|
| 36E79726R0013_1.docx | DOCX document |
Notice history
| Notice | Type | Posted |
|---|---|---|
| 6505--Budesonide/Formoterol INH | Award Notice | |
| 6505--Budesonide/Formoterol INH | Solicitation | |
| This notice | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| 6505--Sacubitril/Valsartan Tablets (VA-27-00014055) | National Acquisition Center | No set-aside | |
| 6505--Imatinib Tablets | National Acquisition Center | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity